vs
汉瑞祥（HSIC）与史丹利百得（SWK）财务数据对比。点击上方公司名可切换其他公司
史丹利百得的季度营收约是汉瑞祥的1.1倍（$3.8B vs $3.4B），汉瑞祥净利率更高（2.9% vs 1.4%，领先1.6%），汉瑞祥同比增速更快（7.7% vs 0.1%），汉瑞祥自由现金流更多（$338.0M vs $155.3M），过去两年汉瑞祥的营收复合增速更高（4.1% vs 0.3%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
史丹利百得是美国知名的工业工具、家用五金产品制造商，同时提供安防类产品，前身为史丹利工具有限公司，由史丹利与百得于2010年3月12日合并而来，总部位于康涅狄格州大哈特福德地区的新不列颠市。
HSIC vs SWK — 直观对比
营收规模更大
SWK
是对方的1.1倍
$3.4B
营收增速更快
HSIC
高出7.6%
0.1%
净利率更高
HSIC
高出1.6%
1.4%
自由现金流更多
HSIC
多$182.7M
$155.3M
两年增速更快
HSIC
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $3.8B |
| 净利润 | $101.0M | $51.4M |
| 毛利率 | 30.9% | 31.4% |
| 营业利润率 | 4.7% | — |
| 净利率 | 2.9% | 1.4% |
| 营收同比 | 7.7% | 0.1% |
| 净利润同比 | 7.4% | -43.6% |
| 每股收益（稀释后） | $0.85 | $0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICSWK
| Q4 25 | $3.4B | — | ||
| Q3 25 | $3.3B | $3.8B | ||
| Q2 25 | $3.2B | $3.9B | ||
| Q1 25 | $3.2B | $3.7B | ||
| Q4 24 | $3.2B | $3.7B | ||
| Q3 24 | $3.2B | $3.8B | ||
| Q2 24 | $3.1B | $4.0B | ||
| Q1 24 | $3.2B | $3.9B |
净利润HSICSWK
| Q4 25 | $101.0M | — | ||
| Q3 25 | $101.0M | $51.4M | ||
| Q2 25 | $86.0M | $101.9M | ||
| Q1 25 | $110.0M | $90.4M | ||
| Q4 24 | $94.0M | $194.9M | ||
| Q3 24 | $99.0M | $91.1M | ||
| Q2 24 | $104.0M | $-11.2M | ||
| Q1 24 | $93.0M | $19.5M |
毛利率HSICSWK
| Q4 25 | 30.9% | — | ||
| Q3 25 | 30.7% | 31.4% | ||
| Q2 25 | 31.4% | 27.0% | ||
| Q1 25 | 31.6% | 29.9% | ||
| Q4 24 | 31.1% | 30.8% | ||
| Q3 24 | 31.3% | 29.9% | ||
| Q2 24 | 32.5% | 28.4% | ||
| Q1 24 | 31.9% | 28.6% |
营业利润率HSICSWK
| Q4 25 | 4.7% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 4.9% | 3.4% | ||
| Q3 24 | 4.9% | 10.6% | ||
| Q2 24 | 5.1% | 9.5% | ||
| Q1 24 | 4.7% | 8.3% |
净利率HSICSWK
| Q4 25 | 2.9% | — | ||
| Q3 25 | 3.0% | 1.4% | ||
| Q2 25 | 2.7% | 2.6% | ||
| Q1 25 | 3.5% | 2.4% | ||
| Q4 24 | 2.9% | 5.2% | ||
| Q3 24 | 3.1% | 2.4% | ||
| Q2 24 | 3.3% | -0.3% | ||
| Q1 24 | 2.9% | 0.5% |
每股收益（稀释后）HSICSWK
| Q4 25 | $0.85 | — | ||
| Q3 25 | $0.84 | $0.34 | ||
| Q2 25 | $0.70 | $0.67 | ||
| Q1 25 | $0.88 | $0.60 | ||
| Q4 24 | $0.75 | $1.29 | ||
| Q3 24 | $0.78 | $0.60 | ||
| Q2 24 | $0.80 | $-0.07 | ||
| Q1 24 | $0.72 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | $268.3M |
| 总债务越低越好 | $2.3B | $5.3B |
| 股东权益账面价值 | $3.2B | $9.0B |
| 总资产 | $11.2B | $21.8B |
| 负债/权益比越低杠杆越低 | 0.71× | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资HSICSWK
| Q4 25 | $156.0M | — | ||
| Q3 25 | $136.0M | $268.3M | ||
| Q2 25 | $145.0M | $311.8M | ||
| Q1 25 | $127.0M | $344.8M | ||
| Q4 24 | $122.0M | $290.5M | ||
| Q3 24 | $126.0M | $298.7M | ||
| Q2 24 | $138.0M | $318.5M | ||
| Q1 24 | $159.0M | $476.6M |
总债务HSICSWK
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | $5.3B | ||
| Q2 25 | $2.1B | $5.6B | ||
| Q1 25 | $2.0B | $5.6B | ||
| Q4 24 | $1.8B | $6.1B | ||
| Q3 24 | $1.9B | $6.1B | ||
| Q2 24 | $1.9B | $6.1B | ||
| Q1 24 | $2.0B | $6.1B |
股东权益HSICSWK
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.4B | $9.0B | ||
| Q2 25 | $3.4B | $9.1B | ||
| Q1 25 | $3.3B | $8.8B | ||
| Q4 24 | $3.4B | $8.7B | ||
| Q3 24 | $3.5B | $8.9B | ||
| Q2 24 | $3.5B | $8.7B | ||
| Q1 24 | $3.6B | $8.9B |
总资产HSICSWK
| Q4 25 | $11.2B | — | ||
| Q3 25 | $11.1B | $21.8B | ||
| Q2 25 | $10.9B | $22.5B | ||
| Q1 25 | $10.5B | $22.5B | ||
| Q4 24 | $10.2B | $21.8B | ||
| Q3 24 | $10.6B | $22.5B | ||
| Q2 24 | $10.3B | $22.5B | ||
| Q1 24 | $10.1B | $23.9B |
负债/权益比HSICSWK
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.64× | 0.59× | ||
| Q2 25 | 0.61× | 0.62× | ||
| Q1 25 | 0.59× | 0.63× | ||
| Q4 24 | 0.54× | 0.70× | ||
| Q3 24 | 0.54× | 0.69× | ||
| Q2 24 | 0.54× | 0.70× | ||
| Q1 24 | 0.56× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | $221.2M |
| 自由现金流经营现金流 - 资本支出 | $338.0M | $155.3M |
| 自由现金流率自由现金流/营收 | 9.8% | 4.1% |
| 资本支出强度资本支出/营收 | 1.3% | 1.8% |
| 现金转化率经营现金流/净利润 | 3.77× | 4.30× |
| 过去12个月自由现金流最近4个季度 | $573.0M | $369.6M |
8季度趋势，按日历期对齐
经营现金流HSICSWK
| Q4 25 | $381.0M | — | ||
| Q3 25 | $174.0M | $221.2M | ||
| Q2 25 | $120.0M | $214.3M | ||
| Q1 25 | $37.0M | $-420.0M | ||
| Q4 24 | $204.0M | $679.1M | ||
| Q3 24 | $151.0M | $285.8M | ||
| Q2 24 | $296.0M | $573.0M | ||
| Q1 24 | $197.0M | $-431.0M |
自由现金流HSICSWK
| Q4 25 | $338.0M | — | ||
| Q3 25 | $141.0M | $155.3M | ||
| Q2 25 | $88.0M | $134.7M | ||
| Q1 25 | $6.0M | $-485.0M | ||
| Q4 24 | $168.0M | $564.6M | ||
| Q3 24 | $117.0M | $199.3M | ||
| Q2 24 | $259.0M | $485.8M | ||
| Q1 24 | $156.0M | $-496.7M |
自由现金流率HSICSWK
| Q4 25 | 9.8% | — | ||
| Q3 25 | 4.2% | 4.1% | ||
| Q2 25 | 2.7% | 3.4% | ||
| Q1 25 | 0.2% | -13.0% | ||
| Q4 24 | 5.3% | 15.2% | ||
| Q3 24 | 3.7% | 5.3% | ||
| Q2 24 | 8.3% | 12.1% | ||
| Q1 24 | 4.9% | -12.8% |
资本支出强度HSICSWK
| Q4 25 | 1.3% | — | ||
| Q3 25 | 1.0% | 1.8% | ||
| Q2 25 | 1.0% | 2.0% | ||
| Q1 25 | 1.0% | 1.7% | ||
| Q4 24 | 1.1% | 3.1% | ||
| Q3 24 | 1.1% | 2.3% | ||
| Q2 24 | 1.2% | 2.2% | ||
| Q1 24 | 1.3% | 1.7% |
现金转化率HSICSWK
| Q4 25 | 3.77× | — | ||
| Q3 25 | 1.72× | 4.30× | ||
| Q2 25 | 1.40× | 2.10× | ||
| Q1 25 | 0.34× | -4.65× | ||
| Q4 24 | 2.17× | 3.48× | ||
| Q3 24 | 1.53× | 3.14× | ||
| Q2 24 | 2.85× | — | ||
| Q1 24 | 2.12× | -22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
SWK
| Tools And Outdoor Segment | $3.3B | 87% |
| Engineered Fastening Segment | $500.5M | 13% |
